Ticker ADMA – ADMA Biologics Inc – sales, description, marketcap – Tickerday.com

ADMA

ADMA Biologics Inc

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 190.83M; Volume: 387.27K; AvgVol 3m: 6.09M; Beta: 1.96;

Cost estimate:

P/E: –; EPS: -0.87; EPS growth quarter/prev quarter: 7.70%;

EPS growth this year: 38.90%; EPS growth past 5 years: 13.30%;

EPS ttm: -0.87;

P/S: 05.04; P/B: 2.72; P/Cashflow: 2.47; P/FCF: ;

Sales: 37.25M; Sales growth quarter/prev quarter: 18.20%; Sales growth past 5 years: 37.80%;

Profitability:

Gross Margin: -34.10%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -36.80%; ROE – return on equity: -104.30%; LT Debt/Equity: 1.26; Total Debt/Equity: 1.26;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.70%; Insider Transactions:10.08%;

Institutional Ownership: 62.70%; Institutional Transactions: 0.52%;

Data update: 07.10.2020.